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Abstract
Background: To assess the effect of visceral adiposity on clinical and pathological characteristics in patients with
endometrial cancer.
Methods: A retrospective review of medical documentation was performed in surgically treated endometrial
cancer patients from January to November 2015 in our institution. The visceral adipose tissue (VAT) and
subcutaneous adipose tissue (SAT) were measured at the level of umbilicus on single-slice computerized
tomography. Visceral adiposity (VAT%) was calculated as VAT/(VAT + SAT).
Results: A total of 200 cases were included in the study. Median age at diagnosis was 54 years old. Most patients
presented with early-stage tumor (86.0 % for I + II) and endometrioid histology (90.5 %). Positive lymph node
occurred in 11.0 % (22/200) of the patients with the median number of retrieved nodes as 25 (range, 4–56). The
entire population had a median body mass index (BMI) of 24.7 kg/m2 and median VAT% of 31.89 %. BMI correlated
with total adipose tissue (correlation coefficient = 0.667, P < 0.001), but not with VAT% (P = 0.495). Viscerally obese
patients tended to be old and post-menopausal (P < 0.001; P = 0.003). Nodal metastasis and extrauterine disease
were more commonly reported in patients with high VAT% (6.0 % vs. 16.0 %, P = 0.024; 9.0 % vs. 19.0 %, P = 0.042,
respectively). Univariate and multivariate logistic regressions were performed to discern the contribution of variable
factors on the lymph node metastasis. Grade (HR = 15.41, 95 % CI = 1.60–148.76; P = 0.018), lympho-vascular invasion
(HR = 449.61, 95 % CI = 31.27–6463.93; P < 0.001) and high VAT% (HR = 6.37, 95 % CI = 1.42–28.69; P = 0.016) retained
statistical significance for predicting lymph node metastasis.
Conclusions: Viscerally obese patients were more likely to be old and have positive lymph node as well as extrauterine
disease. Grade, lympho-vascular invasion presence and visceral adiposity were predictors of nodal disease.
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Background
Endometrial cancer is the most common gynecologic ma-
lignancy in the United States [1]. Although less common
in China, endometrial cancer has been in upward ten-
dency [2], in parallel with the average body weight [3].
Obesity is a well-established risk factor for endometrial
carcinoma [4, 5]. Recently, several investigators have ex-
plored the impact of obesity on prognostic features of
endometrial cancer, primarily using measurements of
body weight and indices of relative weight as an indicator
of overall adiposity [6–12].
Body mass index (BMI) is commonly used in the def-
inition and criteria of obesity. However, it is an imperfect
measurement of body fat distribution that fails to distin-
guish between fat and muscle, and between visceral and
subcutaneous fat [13]. Subcutaneous adipose tissue
(SAT) and visceral adipose tissue (VAT) are different in
* Correspondence: docwuxh@hotmail.com
1Department of Gynecologic Oncology, Fudan University Shanghai Cancer
Center, Shanghai, China
2Department of Oncology, Shanghai Medical College, Fudan University, No
270 Dong-an Road, Xuhui District, 200032 Shanghai, China
Full list of author information is available at the end of the article
© 2016 Ye et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International
License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any
medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Ye et al. BMC Cancer  (2016) 16:209 
DOI 10.1186/s12885-016-2230-4
cellular, molecular, physiological, clinical and prognostic
perspectives [14]. Measurement of VAT has become an
important consideration and has shown to be one of the
most metabolically active fat compartments [14]. Given
that most above-mentioned studies utilized BMI as
measure of obesity and results were conflicting, we felt
it necessary to investigate how VAT correlate with clini-
copathological features of endometrial cancer.
Our institution is located in Shanghai, where the inci-
dence of endometrial cancer increased with overall an-
nual percent changes of 1.66 during the past 30 years
[15]. We conducted this single-institutional retrospective
study mainly for two purposes: firstly, to evaluate the
correlation between BMI and SAT/VAT; secondly, to as-
sess the role of adiposity in clinical and histopathologic
outcomes of endometrial cancer.
Methods
Study patients and data collection
This study was approved by the ethics committee of
Fudan University Shanghai Cancer Center. We searched
the electronic medical record database to identify all the
patients discharged from our department with the chief
diagnosis of endometrial cancer from January 2015 to
November 2015. Patients eligible for study inclusion
fulfilled the following criteria: [1] patients underwent
primary surgery treatment; [2] diagnosis of endometrial
cancer confirmed by pathology; [3] pre-operative ab-
dominal Computerized Tomography (CT) images avail-
able. Figure 1 presents the flow chart of patients
throughout the study. A total of 200 patients were iden-
tified for further analyses. All the included patients gave
their written informed consent.
Fig. 1 Schematic of patients included in the present study. On searching the electronic medical record database, 325 endometrial cancer patients
were discharged from our department from 1 January to 1 November 2015. A total of 283 patients underwent primary surgery during the study
period. Among them, 83 cases were excluded due to the following reasons: no available CT scan (n = 57), incomplete information (n = 9), concurrent
primary ovarian cancer (n = 4), uterine carcinosarcoma (n = 2) and lymphadenectomy not performed (n = 11)
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A comprehensive review of medical documentation
was then performed by a well-trained gynecologic
oncologist. Data collection included age at diagnosis,
menopausal state, comorbid conditions, BMI (calcu-
lated as weight (kg)/[height (m)]2), peritoneal cytology,
tumor size (large tumor diameter recorded in the path-
ology report), histologic subtype, grade, myometrial in-
vasion depth, presence of extrauterine disease, lymph
node status, number of retrieved and positive lymph
nodes, and International Federation of Gynecology and
Obstetrics (FIGO) stage. In our institution, endometrial
cancer patients usually receive complete staging sur-
gery, including peritoneal cytology, total abdominal
hysterectomy, bilateral salpingo-oophorectomy, and
pelvic and para-aortic lymphadenectomy. All the
patients were staged by the FIGO 2014 staging
system [16].
In our routine practice, one surgical specimen is
usually reviewed by two pathologists. Diagnosis was
mainly dependent on the original pathology reports and
pathology review was not conducted in this study. Histo-
logical grade was described by a three-tier system: grade
1 (well differentiated), grade 2 (moderately differenti-
ated), and grade 3 (poorly differentiated and undifferen-
tiated). Serous carcinoma and clear cell carcinoma were
not graded, but all considered as grade 3.
Fig. 2 Measurements of visceral (Pink color) and subcutaneous (blue color) adipose tissue on computerized tomography images. a/b represents
different body fat distribution: both patients’ body mass index is 24.7 kg/m2, while the visceral adipose tissue percentage (VAT%) is 30.3 % (a) and
56.95 % (b), respectively
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Adiposity measurement
Standard CT images based quantitative radiological
measures have been regarded as the gold standard
method for evaluating visceral adiposity [17]. As clearly
shown in Fig. 2, VAT and SAT were measured at the
level of umbilicus (approximately the level of L4-L5)
[17]. SAT is defined as the fat area superficial to the ab-
dominal muscular wall; VAT is deep to the muscular wall,
consisting of the mesenteric, subperitoneal and retroperi-
toneal component. Total adipose tissue was obtained by
adding SAT and VAT. The percentage of visceral fat to
total fat area (VAT%=VAT/[VAT + SAT] × 100) was
Table 1 Clinicopathological features of the study cohort
Parameters Cohort VAT% < 31.89 % VAT% ≥ 31.89 % P value
N = 200 N = 100 N = 100
Median age (range), years 54 (28–84) 52 (28–82) 57 (34–84) <0.001a
Premenopausal patients (%) 83 (41.5 %) 52 (52.0 %) 31 (31.0 %) 0.003b
Hypertension (%) 57 (28.5 %) 19 (19.0 %) 38 (38.0 %) 0.003b
Diabetes (%) 27 (13.5 %) 9 (9.0 %) 18 (18.0 %) 0.063b
Positive peritoneal cytology (%) 16 (9.4 %) n = 171 10 (11.6 %) n = 86 6 (7.1 %) n = 85 0.305b
Histology
Endometrioid (%) 181 (90.5 %) 92 (92.0 %) 89 (89.0 %) 0.381c
Serous (%) 13 (6.5 %) 4 (4.0 %) 9 (9.0 %)
Clear cell (%) 4 (2.0 %) 3 (3.0 %) 1 (1.0 %)
Mucinous (%) 2 (1.0 %) 1 (1.0 %) 1 (1.0 %)
Histological grade
Grade 1 86 (43.0 %) 48 (48.0 %) 38 (38.0 %) 0.069b
Grade 2 85 (42.5 %) 43 (43.0 %) 42 (42.0 %)
Grade 3 29 (14.5 %) 9 (9.0 %) 20 (20.0 %)
Deep myometrial invasion (≥50 %) (%) 46 (23.0 %) 18 (18.0 %) 28 (28.0 %) 0.093b
Average tumor size (range), cm 3.14 (0.2–20) 3.19 (0.3–12) 3.09 (0.2–20) 0.791a
n = 165d n = 84d n = 81d
LN metastasis 22 (11.0 %) 6 (6.0 %) 16 (16.0 %) 0.024b
Median No. retrieved LNs (range) 25 (4–56) 26 (4–55) 24 (4–56) 0.160a
Lympho-vascular invasion (%) 37 (19.9 %) n = 186 17 (18.3 %) n = 93 20 (21.5 %) n = 93 0.582b
Extrauterine disease (%) 28 (14.0 %) 9 (9.0 %) 19 (19.0 %) 0.042b
FIGO stage
IA (%) 134 (67.0 %) 73 (73.0 %) 61 (61.0 %)
IB (%) 23 (11.5 %) 11 (11.0 %) 12 (12.0 %)
II (%) 15 (7.5 %) 7 (7.0 %) 8 (8.0 %)
IIIA (%) 3 (1.5 %) 2 (2.0 %) 1 (1.0 %)
IIIB (%) 2 (1.0 %) 1 (1.0 %) 1 (1.0 %)
IIIC (%) 23 (11.5 %) 6 (6.0 %) 17 (17.0 %)
Median BMI (range), kg/m2 24.7 (17.5–43.7) 24.6 (18.03–43.7) 24.83 (17.53–35.16) 0.280a
Median VAT (range), mm2 17338 (5990–37118) 13780 (5990–31708) 20187(6649–37188) <0.001a
Median SAT (range), mm2 35607 (10458–106902) 41395 (20347–106902) 30360 (10458–61074) <0.001a




dNot all patients have tumor size recorded in the pathology report. Tumor confined within endometrium was reported without tumor size in 14 cases (7 and 7 in
high and low VAT% group, respectively). A total of 21 patients (9 and 12 in high and low VAT% group, respectively) did not have tumor lesion in the final
pathology after dilation and curettage
Abbreviations: LN lymph node, BMI body mass index, SAT subcutaneous Adipose Tissue, VAT visceral adipose tissue, VAT % percentage of visceral adipose tissue
Bold value denotes P with statistical significance
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calculated to provide a single measure of abdominal fat
[18]. ImageJ software [19] is employed for automatic cal-
culation of adipose tissue area on the basis of pre-defined
Hounsfield unit thresholds (-190 to -30). A single radiolo-
gist blinded to the clinicopathological characteristics was
responsible for the measurement.
Statistical analyses
Statistical Package for Social Science (SPSS) statistical
software (Version 17.0, SPSS, Inc., Chicago, IL, USA)
and GraphPad Prism (Version 5.0, GraphPad Software,
Inc., La Jolla, CA, USA) were used for all the analyses.
Continuous data were presented as median (range) and
categorical data as proportions. Parametric Student t
tests were employed in evaluating continuous variables
while Chi-squared tests for categorical counterpart.
Locally weighted scatter plot smoothing curves and
Pearson’s correlation analysis were applied in compari-
son between obesity parameters (BMI, total adipose
tissue, SAT, VAT and VAT%). The associations between
different variables were assessed using univariate and
multivariate logistic regression analysis, and hazard ratio
(HR) with 95 % confidence interval (CI) was calcu-
lated. All of the P values reported were two-sided,




Of 325 patients admitted into our hospital, 283 patients
underwent primary surgery treatment (Fig. 1). Medical
records were reviewed for the 283 consecutive patients.
Among them, 57 patients didn't have available CT im-
ages due to outside hospital CT scan or other imaging
modalities in our institution. We further excluded 26
cases: incomplete information (n = 9), synchronous pri-
mary cancers of the endometrium and ovary (n = 4),
uterine carcinosarcoma (n = 2) and no lymphadenectomy
performed (n = 11). Consequently, our study population
consisted of 200 patients.
Table 1 presents the clinical and pathological charac-
teristics of the entire cohort. Median age at diagnose
was 54 years old (range, 28–84) and premenopausal pa-
tients accounted for 41.5 % (83/200). Medical comorbid-
ities existed in 28.5 % (57/200) and 13.5 % (27/200)
patients for hypertension and diabetes, respectively.
Most tumors were endometrioid histology (90.5 %) and
well to moderately differentiated (85.5 %). Deep myome-
trial invasion was reported in 23.0 % (46/200) of the
cases. Comprehensive nodal status evaluation revealed
that 11.0 % (22/200) of the patients had lymph node
metastasis with median number of retrieved nodes as 25
(range, 4–56). Patients tended to have early-stage disease:
78.5 % stage I, 7.5 % stage II, and 14.0 % stage III. The rate
of positive peritoneal cytology and lympho-vascular inva-
sion was 9.4 % (16/171) and 19.9 % (37/186), respectively.
Associations between obesity-related indices
Measurements of obesity are listed in the bottom part of
Table 1. The median BMI for the entire cohort was
24.7 kg/m2, falling into the overweight category (BMI,
23.0–24.9 kg/m2) per World Health Organization guide-
line for Asia-Pacific populations [20]. VAT accounted for
31.89 % of the total adipose tissue, ranging from 13.97 %
to 59.57 %.
We looked into the associations between obesity-
related variables, which is presented in Table 2. BMI cor-
related well with total adipose tissue (correlation coeffi-
cient = 0.667) with statistical significance (P < 0.001). Not
surprisingly, no correlation was found between BMI and
VAT% (P = 0.495). Figure 3 illustrates scatter plots of
BMI versus total adipose tissue, SAT, VAT and
VAT% with locally weighted smoothing curves fitted
in the plots.
Association between VTA and parameters
The entire cohort patients were dichotomized into two
groups based on the median value of VAT% (results
shown in Table 1). Viscerally obese patients were
more likely to be old and post-menopausal (P < 0.001,
P = 0.003, respectively). Hypertension was more commonly
reported in the patients with high VAT% (P = 0.003). Re-
garding pathological features, correlations were noted in
lymph node metastasis (6.0 % vs. 16.0% for low and high
VAT% patients; P = 0.024) and extrauterine disease (9.0 %
vs. 19.0 % for low and high VAT%; P = 0.042), respectively.
VAT percentage was not statistically associated with peri-
toneal cytology, histology, grade, myometrial invasion
depth, tumor size, lympho-vascular invasion and FIGO
stage. It is worth mentioning that the numbers of retrieved
Table 2 Correlations between obesity-related variables
BMI Total SAT VAT VAT%
BMI Correlation coefficient
P value
Total Correlation coefficient 0.667a
P value <0.001
SAT Correlation coefficient 0.610a 0.913a
P value <0.001 <0.001
VAT Correlation coefficient 0.428a 0.646a 0.279a
P value <0.001 <0.001 <0.001
VAT% Correlation coefficient −0.049 −0.123 −0.504a 0.654a
P value 0.495 0.082 <0.001 <0.001
aCorrelation is significant at the 0.01 level (2-tailed)
Abbreviations: BMI body mass index, Total total adipose tissue, SAT subcutaneous
adipose tissue, VAT visceral adipose tissue, VAT% percentage of visceral
adipose tissue
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lymph nodes were not significantly different between two
groups (median number 26 vs. 24; P = 0.160).
Given the controversial role of lymphadenectomy in
endometrial cancer, we further performed univariate and
multivariate logistic regression to discern the contribu-
tion of variable factors on the lymph node metastasis
(Tables 3 and 4). Given that tumor less than 2 cm has
been suggested as indicative of low-risk for nodal metas-
tases, tumor was dichotomized at the level of 2cm [21,
22]. When nodal disease was the dependent variable in
univariate analysis, the following parameters were
statistically significant: grade 3 (P = 0.001), tumor ≥2 cm
(P = 0.010), deep myometrial invasion (P < 0.001),
lympho-vascular invasion presence (P < 0.001), and high
VAT% (P = 0.029). On multivariate analysis, lymph node
metastasis was significantly associated with grade
(HR = 15.41, 95 % CI = 1.60–148.76; P = 0.018), lympho-
vascular invasion (HR = 449.61, 95 % CI = 31.27–6463.93;
P < 0.001) and high VAT% (HR = 6.37, 95 % CI = 1.42–
28.69; P = 0.016).
Discussion
The effect of obesity on endometrial cancer has been of
interest for decades. Several publications focused on the
impact of obesity on clinical and pathological features of
endometrial cancer, yet leading to inconsistent findings
[6, 7, 9–12]. Everett et al [6] found that patients with a
BMI of >40 kg/m2 frequently had favorable stage I endo-
metrial cancers. A population-based study from Norway
investigated the relationship between BMI and a large
Fig. 3 Scatter-plots of body mass index versus different fat distribution parameters. Total adipose tissue (a), subcutaneous adipose tissue (b), visceral
adipose tissue (c), and visceral adipose tissue percentage (d)
Ye et al. BMC Cancer  (2016) 16:209 Page 6 of 9
panel of clinicopathological data [10]. In their series, high
BMI was significantly associated with markers of non-
aggressive disease, including low FIGO stage and low/
intermediate grade [10]. In contrast, the Women’s Health
Initiative study reported that neither BMI nor waist-to-hip
ratio correlated with stage or grade of disease [11]. Mean-
while, the authors suggested that additional measurement
of adiposity should be considered [11], which was one of
the inspiration sources for the present study.
In this cohort of 200 patients with endometrial cancer,
we found that patients with high VAT% were more apt
to be old and post-menopausal with statistical significance.
The differences in clinicopathological features between the
patients with low and high VAT% lied in the incidence of
positive nodes (6.0 % vs. 16.0 %; P = 0.024) and extrauterine
disease (9.0 % vs. 19.0 %, P = 0.042). In addition, grade 3,
lympho-vascular invasion presence and high VAT% and
were independent predictive factors for lymph node metas-
tasis after adjusting for other variables. We suggested that
high VAT% might be a marker of aggressive disease, which
however warrants further investigation and validation.
Given the consideration and controversy of omitting
lymphadenectomy in endometrial cancer, we hoped to
collect more cases in our future study in order to establish
a model, incorporating several prognostic variables (i.e.
grade, lympho-vascular invasion and VAT%), to evaluate
the risk of lymph node metastasis on individual basis.
Despite that no direct mechanism has ever been eluci-
dated, recent works have improved our understanding of
the association between visceral adiposity and carcino-
genesis [23–25]. Compared to subcutaneous fat depots,
visceral counterpart is considered to be more pro-
inflammatory and pro-tumorigenic because of the
increased circulation of cytokines and growth factors,
promoting tumorigenesis and tumor progression [24],
Table 3 Univariate analysis of factors predictive of lymph node metastasis
Univariate
Parameters Category Cases HR (95 % CI) P value
Age <54 102 1.58 (0.64–3.89) 0.319
≥54 98
BMI <24.7 101 1.02 (0.42–2.48) 0.960
≥24.7 99
Cytology Negative 155 1.44 (0.30–6.99) 0.652
Positive 16
Grade 1 + 2 171 5.47 (2.08–14.41) 0.001
3 29
Tumor size <2cm 69 14.59 (1.92–111.14) 0.010
≥2cm 117
Histology Endometrioid 181 1.95 (0.90–4.20) 0.090
Non-endometrioid 19
Myometrial invasion depth <50 % 154 10.16 (3.82–26.99) <0.001
≥50 % 46
LVSI Negative 149 86.47 (18.58–402.47) <0.001
Positive 37
Extrauterine disease No 172 Not applicablea 0.994
Yes 28
VAT% <31.89 100 2.98 (1.12–7.98) 0.029
≥31.89 100
aEstimation terminated at iteration number 20 because maximum iteration has been reached. Final solution cannot be found
Abbreviations: HR hazard ratio, CI confidence interval, BMI body mass index, LVSI lympho-vascular invasion, VAT% percentage of visceral adipose tissue
Bold value denotes P with statistical significance
Table 4 Analysis of factors predictive of lymph node metastasis
Multivariate
Parameters HR (95 % CI) P value
Grade 15.41 (1.60–148.76) 0.018
Tumor size 0.22 (0.04–1.42) 0.112
Myometrial invasion depth 1.40 (0.28–6.95) 0.679
LVSI 449.61 (31.27–6463.93) <0.001
VAT% 6.37 (1.42–28.69) 0.016
Abbreviations: HR hazard ratio, CI confidence interval, LVSI lympho-vascular in-
vasion, VAT% percentage of visceral adipose tissue
Bold value denotes P with statistical significance
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which might be the underlying reason of our results.
The mechanisms by which visceral obesity is thought to
promote tumorigenesis are manifold, including alter-
ations in adipokine secretion, as well as hyperinsuline-
mia and subsequent stimulation of insulin-like growth
factor-1 axis [25]. Besides, the abundant inflammatory
cells in visceral adiposity create systemic inflammation
and a pro-tumorigenic environment [25].
The widely accepted and used BMI criteria is not suit-
able for determining visceral obesity, as within each
category of BMI there could be substantial individual vari-
ations in visceral adiposity (clear shown in Fig. 2) [13].
Additionally, Asian adults generally have a slighter phys-
ique than Western population, with a less central body
weight distribution [26], so VAT might be a more accurate
measure of obesity in Asian individuals than BMI. In our
series, BMI correlated well with total adipose tissue, but
not with VAT%. Therefore, we suggested that VAT%
might be an important surrogate for obesity in addition to
BMI. In the current time, CT image-based quantitative
measurement of body adiposity is still primarily reserved
for research purpose. With the introduction of commer-
cially available software that does not require special train-
ing, VAT assessment using CT scan could be simple and
accurate [27]. However, what is unknown is the acceptable
threshold level of VAT, above which it begins to detrimen-
tally affect metabolic and inflammatory processes, ultim-
ately inducing tumor progression [28]. We dichotomized
the study population according to the median VAT%
value. The lack of appropriate threshold might hinder the
ability to make useful correlation between visceral obesity
and markers of tumor phenotype.
Our study has limitations inherent to its retrospective
design, including non-randomization, possible selection
bias and completeness of previously recorded data. In
addition, this cohort was restricted to a single institu-
tion, one of the leading cancer centers in China. Thus,
there is a possibility of patient selection bias, which
might hinder the extrapolation of our results to other
population. A large multicenter study would help to
confirm and validate our findings.
Conclusions
Visceral obesity defined by VAT% proved to an inde-
pendent factor for lymph node metastasis in endometrial
cancer, along with the grade 3 disease and presence of
lympho-vascular invasion. Patients with high VAT%
tended to be old and have extrauterine disease. BMI was
associated with total adiposity but not with VAT%.
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